Simulating survival data when one subgroup lacks information
In this paper, we aim to show the process of simulating survival data when the distribution of the overall population and one subgroup (called "positive subgroup") as well as the proportion of the subgroup is known, while the distribution of the other subgroup (called "negative subgroup") is unknown. We propose a combination method which generates survival data of the positive subgroup and negative subgroup, respectively, and survival data of the overall population are the combination of the two subgroups. The parameters of the overall population and the positive subgroup need to satisfy certain constraints, otherwise the parameters may lead to contradictions. From simulation, we show that our proposed combination method can reflect the correlation between the test statistics of overall population and positive subgroup, which makes the simulated data more realistic and the results of simulation more reliable. Moreover, for a multiplicity control in trial design, the combination method can help to determine the α splitting strategy between primary endpoints, and is helpful in designs of clinical trials as shown in three applications.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
---|---|
Enthalten in: |
Journal of biopharmaceutical statistics - (2023) vom: 26. Juli, Seite 1-13 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhao, Yiqi [VerfasserIn] |
---|
Links: |
---|
Themen: |
Correlation |
---|
Anmerkungen: |
Date Revised 27.07.2023 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1080/10543406.2023.2236218 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM359962610 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM359962610 | ||
003 | DE-627 | ||
005 | 20231226082007.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/10543406.2023.2236218 |2 doi | |
028 | 5 | 2 | |a pubmed24n1199.xml |
035 | |a (DE-627)NLM359962610 | ||
035 | |a (NLM)37496254 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhao, Yiqi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Simulating survival data when one subgroup lacks information |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 27.07.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a In this paper, we aim to show the process of simulating survival data when the distribution of the overall population and one subgroup (called "positive subgroup") as well as the proportion of the subgroup is known, while the distribution of the other subgroup (called "negative subgroup") is unknown. We propose a combination method which generates survival data of the positive subgroup and negative subgroup, respectively, and survival data of the overall population are the combination of the two subgroups. The parameters of the overall population and the positive subgroup need to satisfy certain constraints, otherwise the parameters may lead to contradictions. From simulation, we show that our proposed combination method can reflect the correlation between the test statistics of overall population and positive subgroup, which makes the simulated data more realistic and the results of simulation more reliable. Moreover, for a multiplicity control in trial design, the combination method can help to determine the α splitting strategy between primary endpoints, and is helpful in designs of clinical trials as shown in three applications | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Subgroup | |
650 | 4 | |a correlation | |
650 | 4 | |a exponential distribution | |
650 | 4 | |a simulations | |
650 | 4 | |a survival data | |
700 | 1 | |a Yan, Ping |e verfasserin |4 aut | |
700 | 1 | |a Yang, Xinfeng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of biopharmaceutical statistics |d 1991 |g (2023) vom: 26. Juli, Seite 1-13 |w (DE-627)NLM012811432 |x 1520-5711 |7 nnns |
773 | 1 | 8 | |g year:2023 |g day:26 |g month:07 |g pages:1-13 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/10543406.2023.2236218 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2023 |b 26 |c 07 |h 1-13 |